To date, solving structures of potential therapeutics using X-ray diffraction (XRD) has been a pivotal step in the drug development process. But a recent paper by a team of researchers led by NanoImaging Services shows how microcrystal electron diffraction (MicroED) is growing to obtain the structures of potential pharmaceuticals.
Click here for original story, Microcrystal electron diffraction supports a new drug development pipeline
Source: Phys.org